Suboxone and Breast cancer recurrent - a phase IV clinical study of FDA data

Summary:

Breast cancer recurrent is reported only by a few people who take Suboxone.

The phase IV clinical study analyzes which people take Suboxone and have Breast cancer recurrent. It is created by eHealthMe based on reports of 26,417 people who have side effects while taking Suboxone from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

26,417 people reported to have side effects when taking Suboxone.
Among them, 4 people (0.02%) have Breast cancer recurrent.

What is Suboxone?

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in opiate withdrawal. eHealthMe is studying from 29,166 Suboxone users for its effectiveness, alternative drugs and more.

What is Breast cancer recurrent?

Breast cancer recurrent is found to be associated with 627 drugs and 295 conditions by eHealthMe.

Number of Suboxone and Breast cancer recurrent reports submitted per year:

Could Suboxone cause Breast cancer recurrent?

Age of people who have Breast cancer recurrent when taking Suboxone *:

Common drugs people take besides Suboxone *:

Wellbutrin: 1 person, 25.00%
Lorazepam: 1 person, 25.00%
Lasix: 1 person, 25.00%
Gralise: 1 person, 25.00%
Cymbalta: 1 person, 25.00%

Common side effects people have besides Breast cancer recurrent *:

Respiratory Syncytial Virus Infection (viral disease of respiratory system): 1 person, 25.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 1 person, 25.00%
Metastases To Spine (cancer spreads to spine): 1 person, 25.00%
Metastases To Neck (cancer spreads to neck): 1 person, 25.00%
Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 25.00%
Breast Cancer Metastatic: 1 person, 25.00%

Common conditions people have *:

Drug Dependence: 3 people, 75.00%
Swelling: 1 person, 25.00%
Neuralgia (pain in one or more nerves): 1 person, 25.00%
Depression: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Suboxone and have Breast cancer recurrent?

Check whether Breast cancer recurrent is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Breast cancer recurrent and when was it recovered:

Breast cancer recurrent in Suboxone

Expand to all the drugs that have ingredients of buprenorphine hydrochloride; naloxone hydrochloride:

Breast cancer recurrent and drugs with ingredients of buprenorphine hydrochloride; naloxone hydrochloride

Alternative drugs to, pros and cons of Suboxone:

Suboxone (29,166 reports)

Common Suboxone side effects:

Pain: 2,839 reports
Drug abuse: 2,370 reports
Stress and anxiety: 1,734 reports
Nausea and vomiting: 1,641 reports
Insomnia (sleeplessness): 1,528 reports

Browse all side effects of Suboxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Breast cancer recurrent treatments and more:

Breast cancer recurrent (5,958 reports)

COVID vaccines that are related to Breast cancer recurrent:

Common drugs associated with Breast cancer recurrent:

How the study uses the data?

The study uses data from the FDA. It is based on buprenorphine hydrochloride; naloxone hydrochloride (the active ingredients of Suboxone) and Suboxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.